Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 172
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04744363 | Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab) | ||
| NCT05264506 | Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive | ||
| NCT04310085 | Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites | ||
| NCT04605094 | Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis | ||
| NCT04280029 | SELUTION SLR™ 014 In-stent Restenosis | ||
| NCT03627715 | Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan | ||
| NCT03994328 | An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD | ||
| NCT05066698 | ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects | ||
| NCT05267613 | Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. | ||
| NCT04568031 | Study of AZD1222 for the Prevention of COVID-19 in Japan | ||
| NCT04053387 | Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003) | ||
| NCT02846753 | Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts | ||
| NCT02374450 | A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine | ||
| NCT03649152 | Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan | ||
| NCT04818801 | Safety, Reactogenicity and Immunogenicity Study of ReCOV | ||
| NCT03976518 | Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial) | ||
| NCT03254446 | Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension | ||
| NCT05859854 | Cenobamate in Adults With Focal-Onset Seizures | ||
| NCT03980483 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate | ||
| NCT02953652 | Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | ||
| NCT03881488 | Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies | ||
| NCT04535986 | A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD | ||
| NCT04980638 | Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia | ||
| NCT05874804 | Carry Life@ UF System Clinical Study | ||
| NCT05599334 | A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib | ||
| NCT04201132 | Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System | ||
| NCT04125290 | US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI) | ||
| NCT05508750 | Growth and Safety Clinical Trial on a New Infant Formula | ||
| NCT07475468 | CP382 - Intermittent Catheter (IC) PRO Panel Plan | ||
| NCT04814680 | Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration Rate | ||
| NCT05985083 | A Study Of IMM47 In Subjects With Advanced Solid Tumors | ||
| NCT05632211 | A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants | ||
| NCT03369262 | PoC Study of OBE022 in Threatened Preterm Labour | ||
| NCT05560646 | A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain | ||
| NCT05169307 | CPX-351 Real-World Effectiveness and Safety Study | ||
| NCT05843916 | Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease | ||
| NCT04324437 | eRAPID: Online Symptom Reporting in Lung Cancer | ||
| NCT05414422 | A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD | ||
| NCT03077477 | Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers | ||
| NCT04376554 | Effect of Tebipenem on Normal Human Intestinal Microbiota | ||
| NCT04078152 | Durvalumab Long-Term Safety and Efficacy Study | ||
| NCT06716801 | Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain | ||
| NCT03983980 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) | ||
| NCT04625972 | Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults | ||
| NCT02734004 | A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. | ||
| NCT04206917 | MultiPulse Therapy (MPT) for AF | ||
| NCT04027439 | Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler | ||
| NCT07377682 | Real-world Clinical Response to Trazodone in Italy, Poland, and Romania | ||
| NCT03970837 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) | ||
| NCT04719832 | Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype |
